Fresh covid outbreaks in countries which have extensively used Chinese vaccines on a significant percentage of populations fuel doubt over efficacy of these vaccines.
In a separate trial in Serbia, 29% of 150 participants were found to have zero antibodies against the virus even after three months. In addition, the average age of the people who participated in the Serbian study was higher than 65.